Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05519982 · ClinicalTrials.gov registry record · NA
Sleep Treatment Education Program-1 (STEP-1)
A NA study, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT05519982: Completed NA study, sponsored by Dana-Farber Cancer Institute.
NCT05519982 is a NA study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 70 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05519982, a NA study, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
The purpose of the study is to learn if single session online education programs can help improve cancer survivors' sleep.
Primary Outcome
The Insomnia Severity Index (ISI) is a 7-item measure used to evaluate insomnia severity (e.g. dissatisfaction with sleep and worry about sleep problems). Item response values are totaled to calculate a total ISI score ranging from 0-28, with higher scores indicating more insomnia symptom burden.
Interventions
- BEHAVIORAL Enhanced Usual Care
- BEHAVIORAL Sleep Treatment Education Program (STEP-1)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2023-03-10 |
| Est. Completion | 2024-10-11 |
| Phase | NA |
What the finished NCT05519982 record still lists
NCT05519982 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Enhanced Usual Care is the first listed.
NCT05519982 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05519982 about?
NCT05519982 is a clinical study titled "Sleep Treatment Education Program-1 (STEP-1)". The purpose of the study is to learn if single session online education programs can help improve cancer survivors' sleep.
What is the current status of trial NCT05519982?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2023-03-10. Estimated completion is 2024-10-11.
What interventions are being tested in trial NCT05519982?
The interventions under investigation include: Enhanced Usual Care (BEHAVIORAL), Sleep Treatment Education Program (STEP-1) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05519982?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05519982's enrollment target sits among peer trials
70 1103rd of 2000 higher than 868 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI